Hypertension Startups in APAC

There are 29 Hypertension digital health ventures in APAC. Over the past 5 years, the CAGR has not expanded. The average maturity of digital health ventures in Hypertension is 51.3.

In total, $1.13B of digital health venture capital has been raised across 72 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
Airdoc (鹰瞳)	Medical Imaging	China	$ 123.46 B	$ 123.46 B	IPO	$ 214.00 M	Toggle
Arblet (Arblet)	Wearables	Japan	$ 123.46 B	$ 123.46 B	Seed	undisclosed	Toggle
AYK (爱怡康健)	Hospital	China	$ 123.46 B	$ 123.46 B	Series B	$ 50.00 M	Toggle
BAILT (百联通医疗)	Remote Monitoring Devices	China	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
Biofourmis	Prescriptive Analytics	Singapore	$ 123.46 B	$ 123.46 B	Series D1	$ 20.00 M	Toggle
CardioRay (尚盈医疗)	Remote Monitoring Devices	China	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
Carelinker (蓝信康)	Disease Management	China	$ 123.46 B	$ 123.46 B	Series A	$ 1.41 M	Toggle
Codoon Health (咕咚健康)	Digital Therapeutics	China	$ 123.46 B	$ 123.46 B	Angel	undisclosed	Toggle
CureApp (CureApp)	Digital Therapeutics	Japan	$ 123.46 B	$ 123.46 B	Series D	$ 52.24 M	Toggle
DearJane Medical	Consumer Marketplace	Australia	$ 123.46 B	$ 123.46 B	Angel	$ 0.06 M	Toggle

Showing 1 to 10 of 29 entries